Webinar on Heart Failure, Diabetes and Renal Failure: The Emerging Role of SGLT-2 Inhibition
Donnerstag, 25. Februar 2021, 17:00 - 18:30 Uhr CET
Programm und GRATIS-Anmeldung hier!
Covid-19 Update: Postponement of first course module
As COVID-19 is presenting unprecedented global challenges and considering the current uncertainty associated with planning major events during this period, the Zurich Heart House has taken the decision to postpone the start of the 2nd edition of the Postgraduate Course in Heart Failure London which was scheduled to take place on February 10-13, 2020 in London.
The decision was taken after careful consideration and active monitoring of the COVID-19 developments and to protect the health and well-being of our delegates, partners, faculty and staff.
The new date to start the PCHF London will be June 23-26, 2021.
We are confident that by then the course can be held safely. The date of the last module will be maintained by 12-15 October 2022. Two modules will be held in 2021 and four modules in 2022.
Accordingly, deadline for application will also be postponed to 31 March 2021. The submitted applications will be reviewed by the course directors in April and notification about acceptance will be communicated early May 2021.
Do not miss this opportunity to learn from the best and become an expert in the field of Heart Failure
Application deadline: 28 February 2021
The Zurich Heart House, known throughout the world for its excellence in providing postgraduate courses in heart failure, has created the perfect course for you: the online Postgraduate Course in Heart Failure London (PCHF London online)!
Do not miss this great opportunity to learn at home, on your own time and pace, from the best in the field of heart failure.
The Zurich Heart House is a center of excellence focused on cardiovascular research.
Being recognized as a platform for educational programs including scientific and clinical meetings, the Zurich Heart House (ZHH) is also the home of the editorial office of a renowned scientific journal. Due to these multiple functions that the ZHH supports, naturally, it is an integral part of an international network within the field of cardiovascular medicine.
Collectively, the ZHH enables synergistic collaborations and possibilities to promote the field of cardiovascular research and professional education. These multiple possibilities improve the research reputation of Zurich and ZHH can also be considered as a think tank for ways to improve patient care. Thus, the ZHH provides a service to the general public, especially those affected with heart disease.